These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21734760)

  • 1. Dengue vaccine roll-out: getting ahead of the game.
    Zorlu G; Fleck F
    Bull World Health Organ; 2011 Jul; 89(7):476-7. PubMed ID: 21734760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection.
    Pitisuttithum P; Bouckenooghe A
    Expert Rev Vaccines; 2016 Jul; 15(7):795-8. PubMed ID: 27171845
    [No Abstract]   [Full Text] [Related]  

  • 3. The demand for a dengue vaccine: a contingent valuation survey in Metro Manila.
    Palanca-Tan R
    Vaccine; 2008 Feb; 26(7):914-23. PubMed ID: 18206277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sanofi's dengue vaccine first to complete phase 3.
    Sinha G
    Nat Biotechnol; 2014 Jul; 32(7):605-6. PubMed ID: 25004214
    [No Abstract]   [Full Text] [Related]  

  • 5. Dengue vaccine poised for roll-out but safety concerns linger.
    Mallapaty S
    Nature; 2022 Nov; 611(7936):434-435. PubMed ID: 36352113
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of multi-country joint regulatory reviews: The experience of a WHO joint technical consultation on the CYD-TDV (Dengvaxia®) dossier.
    Vannice K; Chocarro L; Pfleiderer M; Bellah A; Ward M; Yoon IK; Hombach J
    Vaccine; 2017 Oct; 35(43):5731-5733. PubMed ID: 28755835
    [No Abstract]   [Full Text] [Related]  

  • 7. A recombinant live attenuated tetravalent vaccine for the prevention of dengue.
    Guy B; Noriega F; Ochiai RL; L'azou M; Delore V; Skipetrova A; Verdier F; Coudeville L; Savarino S; Jackson N
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28590795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue vaccine: WHO position paper – July 2016.
    Wkly Epidemiol Rec; 2016 Jul; 91(30):349-64. PubMed ID: 27476189
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program].
    Hernández-Ávila M; Lazcano-Ponce E; Hernández-Ávila JE; Alpuche-Aranda CM; Rodríguez-López MH; García-García L; Madrid-Marina V; López Gatell-Ramírez H; Lanz-Mendoza H; Martínez-Barnetche J; Díaz-Ortega JL; Ángeles-Llerenas A; Barrientos-Gutiérrez T; Bautista-Arredondo S; Santos-Preciado JI
    Salud Publica Mex; 2016; 58(1):71-83. PubMed ID: 26879510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue vaccine: opportunities and challenges.
    Hatch S; Mathew A; Rothman A
    IDrugs; 2008 Jan; 11(1):42-5. PubMed ID: 18175262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of vaccine research and development of vaccines for dengue.
    Vannice KS; Durbin A; Hombach J
    Vaccine; 2016 Jun; 34(26):2934-2938. PubMed ID: 26973072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11-12 May 2009.
    Trent D; Shin J; Hombach J; Knezevic I; Minor P;
    Vaccine; 2010 Dec; 28(52):8246-55. PubMed ID: 21036129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward vaccines for cholera, dengue, malaria, and Ebola.
    Cunningham KC; Hayney MS
    J Am Pharm Assoc (2003); 2014; 54(6):654, 656-7. PubMed ID: 25379984
    [No Abstract]   [Full Text] [Related]  

  • 14. Dengue vaccines: progress and challenges.
    Coller BA; Clements DE
    Curr Opin Immunol; 2011 Jun; 23(3):391-8. PubMed ID: 21514129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue vaccine development: a 75% solution?
    Halstead SB
    Lancet; 2012 Nov; 380(9853):1535-6. PubMed ID: 22975339
    [No Abstract]   [Full Text] [Related]  

  • 16. SAGE committee advice on dengue vaccine.
    Pang T
    Lancet Infect Dis; 2016 Aug; 16(8):880-2. PubMed ID: 27477966
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploring the role of a recently licensed dengue vaccine in Australian travellers.
    Thevarajan I; Torresi J; Simmons C
    Med J Aust; 2020 Feb; 212(3):102-103.e1. PubMed ID: 31909484
    [No Abstract]   [Full Text] [Related]  

  • 18. Dengue vaccine--time to act now.
    Pang T; Thiam DGY; Tantawichien T; Ismail Z; Yoksan S
    Lancet; 2015 May; 385(9979):1725-1726. PubMed ID: 25943934
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of tetravalent dengue vaccine in Thai schoolchildren.
    Moi ML; Takasaki T; Kurane I
    Lancet; 2013 Mar; 381(9872):1094. PubMed ID: 23540846
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of tetravalent dengue vaccine in Thai schoolchildren.
    McKibben L
    Lancet; 2013 Mar; 381(9872):1094. PubMed ID: 23540848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.